DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: Synthesis and antibacterial activity

Bioorganic & Medicinal Chemistry Letters
2009.0

Abstract

The synthesis and antibacterial activities of three chemotypes of DNA supercoiling inhibitors based on imidazolo[1,2-a]pyridine and [1,2,4]triazolo[1,5-a]pyridine scaffolds that target the ATPase subunits of DNA gyrase and topoisomerase IV (GyrB/ParE) is reported. The most potent scaffold was selected for optimization leading to a series with potent Gram-positive antibacterial activity and a low resistance frequency.

Knowledge Graph

Similar Paper

DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: Synthesis and antibacterial activity
Bioorganic & Medicinal Chemistry Letters 2009.0
Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided Design
ACS Medicinal Chemistry Letters 2016.0
Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors
European Journal of Medicinal Chemistry 2017.0
5-(2-Pyrimidinyl)-imidazo[1,2-a]pyridines are antibacterial agents targeting the ATPase domains of DNA gyrase and topoisomerase IV
Bioorganic & Medicinal Chemistry Letters 2009.0
Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site
Journal of Medicinal Chemistry 2015.0
Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors
Journal of Medicinal Chemistry 2016.0
Novel Dual-Targeting Benzimidazole Urea Inhibitors of DNA Gyrase and Topoisomerase IV Possessing Potent Antibacterial Activity: Intelligent Design and Evolution through the Judicious Use of Structure-Guided Design and Stucture−Activity Relationships
Journal of Medicinal Chemistry 2008.0
New N-phenyl-4,5-dibromopyrrolamides as DNA gyrase B inhibitors
MedChemComm 2019.0
Synthesis and Antibacterial Activity of a Novel Series of Potent DNA Gyrase Inhibitors. Pyrazole Derivatives
Journal of Medicinal Chemistry 2004.0
Design, synthesis, and structure–activity relationship studies of ATP analogues as DNA gyrase inhibitors
Bioorganic & Medicinal Chemistry Letters 2000.0